MAPT and Alzheimer disease: To identify the lactylation sites of the in vitro lactylated tau, LC‐MS/MS analysis identified eight lactylated lysine residues in tau, with K331, the most prominent site identified in the human brain upregulated in AD (Figure 2), K369, and potentially K370 showing the highest PSMs (Figure 4F,H, Figure S7, Table S5).